On the other hands, the sensitivity to cisplatin and invasive activities of tumor cells treated with Atg5flox/flox TAM were reduced to the levels of those of LysM-Atg5-/- TAM supernatants in the presence of SB431542 (Fig 2B). This evidence concerns the gene ATG5 and neoplasm.